Solstice, which uses clinical and compliance documents and AI to accelerate advertising approvals for pharma clients, raised a $21M Series A (Brock E.W. Turner/Axios)

Jun 01, 2026 - 04:46
Updated: 1 month ago
0 3
Solstice CEO Aris Saxena discusses the company's $21 million Series A funding round.

Brock E.W. Turner / Axios:
Solstice, which uses clinical and compliance documents and AI to accelerate advertising approvals for pharma clients, raised a $21M Series A  —  Pharma marketing company Solstice raised $21 million in Series A funding led by Transformation Capital, CEO Aris Saxena tells Axios Pro exclusively.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
Christopher Holloway

Christopher Holloway is the founder and director of Progressive Robot, a UK-based technology company. A full-stack engineer with more than two decades of experience, he works across PHP development, ecommerce, Linux infrastructure, technical SEO and AI automation, and writes here on technology, AI, hardware and software.

Comments (0)

User